Search - tctmd.com

Displaying 61 - 80 of 273

Sort: Relevancy | Date

Presentation TCT 2020

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

Presenter: Jaffar Khan

October 14, 2020

Presentation TCT 2020

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

Presenter: Tomoki Ochiai

October 14, 2020

Presentation TCT 2020

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

Presenter: Craig Basman

October 14, 2020

Presentation TCT 2020

TCT 459: Transcatheter Aortic Valve Thrombosis: Data From a French Multicenter Cohort Analysis

Presenter: Geraud Souteyrand

October 14, 2020

Presentation TCT 2020

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Hashrul Rashid

October 14, 2020

Presentation TCT 2020

TCT 455: Reinterventions After Transcatheter Aortic Valve Replacement With a Supraannular Self-Expanding Bioprosthesis

Presenter: Kendra Grubb

October 14, 2020

Presentation TCT 2020

TCT 347: Overexpansion of Balloon-Expandable Aortic Transcatheter Heart Valves in the Mitral Valve Position

Presenter: Mohammed Al-Hijji

October 14, 2020

Presentation TCT 2020

TCT 295: Outcomes With MANTA Device for Large-bore Access Closure After Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 14, 2020

Presentation TCT 2020

TCT 227: The Role of Neighborhood Disadvantage in Predicting Mortality in Patients After Transcatheter Aortic Valve Replacement

Presenter: Jesse Goitia

October 14, 2020

Presentation TCT 2020

TCT 151: Impact of Virtual Reality on Consult Time and Experience for Structural Heart Disease Patients

Presenter: Jorge Mauricio Castellanos

October 14, 2020

Presentation TCT 2020

TCT 148: Impact of Foreshortening in SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve Implantation

Presenter: Shuichi Kegai

October 14, 2020

Presentation TCT 2020

TCT 147: Limitations of Established Cardiac Biomarkers in Low- to Intermediate-Risk TF-TAVR Patients With Advanced CKD

Presenter: Hatim Seoudy

October 14, 2020

Presentation TCT 2020

TCT 145: Wearable Activity Monitoring and the Impact of Frailty on Physical Activity After Transcatheter Aortic Valve Replacement

Presenter: Katherine McGee

October 14, 2020

Presentation TCT 2020

TCT 143: Outcomes of Transcatheter Aortic Valve Replacement After Prior Mitral Valve Surgery

Presenter: Rahul Gupta

October 14, 2020

Presentation TCT 2020

TCT 142: CFD Analysis to Figure Out a Relationship Between Aortic Valve Calcification and Hemodynamic Factors

Presenter: Wookjin Lee

October 14, 2020

Presentation TCT 2020

TCT 140: Direct Implantation of a Supra-Annular Self-Expanding Bioprostheses has no Impact on One-Year Clinical Outcomes

Presenter: Konstantinos Toutouzas

October 14, 2020

Presentation TCT 2020

TCT 139: Hemodynamic Comparison of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Ultra Versus SAPIEN 3: The HomoSAPIEN Registry

Presenter: Noriaki Moriyama

October 14, 2020

Presentation TCT 2020

TCT 137: Autoimmune Connective Tissue Diseases and Aortic Valve Replacement Outcomes, A Population-Based Study

Presenter: Mohamed M. Gad

October 14, 2020

Presentation TCT 2020

TCT 135: Comparison of Outcomes of Redo-Aortic Valve Replacement: Transcatheter Versus Surgical Approach

Presenter: Charles Choi

October 14, 2020

Presentation TCT 2020

TCT 134: Relative Quality of Life Improvement After Transcatheter Aortic Valve Replacement (TAVR) in Patients With Reduced Ejection Fraction.

Presenter: Hamza Lodhi

October 14, 2020

Advertisement

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

TCT 459: Transcatheter Aortic Valve Thrombosis: Data From a French Multicenter Cohort Analysis

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

TCT 455: Reinterventions After Transcatheter Aortic Valve Replacement With a Supraannular Self-Expanding Bioprosthesis

TCT 347: Overexpansion of Balloon-Expandable Aortic Transcatheter Heart Valves in the Mitral Valve Position

TCT 295: Outcomes With MANTA Device for Large-bore Access Closure After Transcatheter Aortic Valve Replacement

TCT 227: The Role of Neighborhood Disadvantage in Predicting Mortality in Patients After Transcatheter Aortic Valve Replacement

TCT 151: Impact of Virtual Reality on Consult Time and Experience for Structural Heart Disease Patients

TCT 148: Impact of Foreshortening in SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve Implantation

TCT 147: Limitations of Established Cardiac Biomarkers in Low- to Intermediate-Risk TF-TAVR Patients With Advanced CKD

TCT 145: Wearable Activity Monitoring and the Impact of Frailty on Physical Activity After Transcatheter Aortic Valve Replacement

TCT 143: Outcomes of Transcatheter Aortic Valve Replacement After Prior Mitral Valve Surgery

TCT 142: CFD Analysis to Figure Out a Relationship Between Aortic Valve Calcification and Hemodynamic Factors

TCT 140: Direct Implantation of a Supra-Annular Self-Expanding Bioprostheses has no Impact on One-Year Clinical Outcomes

TCT 139: Hemodynamic Comparison of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Ultra Versus SAPIEN 3: The HomoSAPIEN Registry

TCT 137: Autoimmune Connective Tissue Diseases and Aortic Valve Replacement Outcomes, A Population-Based Study

TCT 135: Comparison of Outcomes of Redo-Aortic Valve Replacement: Transcatheter Versus Surgical Approach

TCT 134: Relative Quality of Life Improvement After Transcatheter Aortic Valve Replacement (TAVR) in Patients With Reduced Ejection Fraction.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content